Atrium Oasis Drain Single W / AC, Part No. 3600-100
FDA Device Recall #Z-0621-2024 — Class II — November 1, 2023
Recall Summary
| Recall Number | Z-0621-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 1, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Atrium Medical Corporation |
| Location | Merrimack, NH |
| Product Type | Devices |
| Quantity | 835 cases total (6 units/case) |
Product Description
Atrium Oasis Drain Single W / AC, Part No. 3600-100
Reason for Recall
A sterilization nonconformance prematurely aged the product by 48.3 days, resulting in the expiration date on the label not being accurate. This nonconforming product was inadvertently distributed to customers. Increased risk to patients and healthcare providers using the product after the shortened expiration date of November 17, 2025.
Distribution Pattern
Domestic distribution nationwide. No foreign distribution.
Lot / Code Information
UDI-DI 00650862110012 Lots 492065 and 492075
Other Recalls from Atrium Medical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0024-2025 | Class II | iCast Covered Stent, 6MMx16MMx120CM, Model Numb... | Sep 9, 2024 |
| Z-1951-2024 | Class II | ADVANTA VXT, 5X40, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
| Z-1989-2024 | Class II | ADVANTA VXT, 6X80, 1GDS, FH, STR-TW. Single-End... | May 3, 2024 |
| Z-1986-2024 | Class II | ADVANTA VXT, 6X70, 1GDS, FH, STR-TW. Single-End... | May 3, 2024 |
| Z-1960-2024 | Class II | ADVANTA VXT, 7X70, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.